<img src='https://npr.brightspotcdn.com/dims3/default/strip/false/crop/5811×3874+0+0/resize/5811×3874!/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2Fbc%2Fde%2F52a045a443cca25dc1dad309cd64%2Fap24205636899403.jpg' alt='A pharmacist holds a vial of lenacapavir, at the Desmond Tutu Health Foundation's Masiphumelele Research Site, in Cape Town, South Africa. The drug's development has been heralded as the 2024 Breakthrough of the Year by the journal Science, which described it as representing “a pivotal step toward diminishing HIV/AIDS as a global health crisis.”‘/>
That’s the title that Science magazine is bestowing upon the medication called lenacapavir — a twice yearly injectable that prevents infection by the HIV virus.
(Image credit: Nardus Engelbrecht)
